Akari Therapeutics Plc Analysis
| Analyst Ratings |
|
Average Target Price
|
2.75
|
|
Average Rating
|
4.50
|
|
# Strong Buys
|
1
|
|
# Buys
|
1
|
|
# Holds
|
0
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2022-12-31
|
-0.07
|
0.00
|
0.07
|
100.00%
|
|
2022-09-30
|
-0.04
|
-0.04
|
0.00
|
0.00%
|
|
2022-06-30
|
0.00
|
-0.10
|
0.00
|
0.00%
|
|
2022-03-31
|
0.00
|
-0.12
|
0.00
|
0.00%
|
|
2021-09-30
|
0.00
|
-0.03
|
0.00
|
0.00%
|
|
2021-06-30
|
0.00
|
-0.15
|
0.00
|
0.00%
|
|
2021-03-31
|
0.00
|
-0.01
|
0.00
|
0.00%
|
|
2020-09-30
|
0.00
|
0.04
|
0.00
|
0.00%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-0.82
|
|
2019-12-31
|
-0.93
|
|
2018-12-31
|
-1.13
|
|
2017-12-31
|
-3.03
|
|
2016-12-31
|
-1.84
|
|
2015-12-31
|
-12.51
|
|
2013-12-31
|
-0.60
|